ALINT — IntegraGen SA Share News
0.000.00%
Last trade - 00:00- €0.46m
- -€0.35m
- €5.02m
Brief: Integragen H1 revenue 2.8 million euros, up more than 10 pct
Brief: AP-HP and IntegraGen agree to research partnership
Brief: Integragen to present positive results on biomarker mir-31-3p at the 2016 ASCO conference
Brief: Integragen FY net loss widens to 1.5 million euros
Brief: Integragen FY revenue down 7 pct to 5.6 mln euros
Brief: Integragen collaborates with FIRE-3 clinical trial investigators
Brief: Gustave Roussy and Integragen announce completion of over 1000 tests in less than 18 months
Brief: Integragen cash position as of June 30, 2015 of 4.05 mln euros
Brief: Integragen results identify new virus implicated in development of liver cancer
Brief: Integragen H1 revenue rises by 1% to 2.6 mln euros
Brief: Integragen announces cooperation agreement with the Hopital Europeen Georges Pompidou
Brief: Integragen announces positive results of two miR-31-3p biomarker studies
Brief: Integragen announces optional equity line with Societe Generale
Brief: Integragen to present results on MIR31-3P biomarker in lung cancer
Brief: Integragen FY net loss narrows to 1.0 million euros
Brief: Integragen signs contract with L'Institut Pasteur
Brief: Integragen signs distribution deal with Genoma
Brief: Integragen FY 2014 revenue rises by 12% to 6.03 mln euros
Brief: Integragen announces collaboration agreement with Piccolo